The horizon: New targets and new agents.
作者信息
Jazwinski Alison B, Muir Andrew J
机构信息
Division of Gastroenterology, Duke University Medical Center and Duke Clinical Research Institute, Durham, NC.
出版信息
Clin Liver Dis (Hoboken). 2012 Mar 6;1(1):24-27. doi: 10.1002/cld.2. eCollection 2012 Feb.
Abstract
摘要
相似文献
1
The horizon: New targets and new agents.
Clin Liver Dis (Hoboken). 2012 Mar 6;1(1):24-27. doi: 10.1002/cld.2. eCollection 2012 Feb.
2
Use of the Internet in scanning the horizon for new and emerging health technologies: a survey of agencies involved in horizon scanning.
J Med Internet Res. 2003 Jan-Mar;5(1):e6. doi: 10.2196/jmir.5.1.e6.
3
Platelet-rich plasma: a case study for the identification of disinvestment opportunities using horizon scanning.
Aust Health Rev. 2017 Mar;41(1):33-37. doi: 10.1071/AH15075.
4
Postural effects of the horizon on land and at sea.
Psychol Sci. 2011 Jan;22(1):118-24. doi: 10.1177/0956797610392927. Epub 2010 Dec 14.
5
Direct Comparison of the Precision of the New Hologic Horizon Model With the Old Discovery Model.
J Clin Densitom. 2018 Oct-Dec;21(4):524-528. doi: 10.1016/j.jocd.2017.11.001. Epub 2017 Nov 22.
6
To succeed in the long-term, focus on the middle-term.
Harv Bus Rev. 2007 Jul-Aug;85(7-8):84-90, 192.
7
The Rim and the Ancient Mariner: The Nautical Horizon Affects Postural Sway in Older Adults.
PLoS One. 2016 Dec 14;11(12):e0166900. doi: 10.1371/journal.pone.0166900. eCollection 2016.
8
Receding Horizon Stabilization and Disturbance Attenuation for Neural Networks With Time-Varying Delay.
IEEE Trans Cybern. 2015 Dec;45(12):2680-92. doi: 10.1109/TCYB.2014.2381604. Epub 2014 Dec 30.
9
Characterization of oil and water accommodated fractions used to conduct aquatic toxicity testing in support of the Deepwater Horizon oil spill natural resource damage assessment.
Environ Toxicol Chem. 2017 Jun;36(6):1450-1459. doi: 10.1002/etc.3672. Epub 2016 Dec 9.
10
Biologic therapies on the horizon for rheumatoid arthritis.
J Clin Rheumatol. 2004 Jun;10(3 Suppl):S32-9. doi: 10.1097/01.rhu.0000130688.68036.ef.
本文引用的文献
1
Preliminary study of two antiviral agents for hepatitis C genotype 1.
N Engl J Med. 2012 Jan 19;366(3):216-24. doi: 10.1056/NEJMoa1104430.
2
Response-guided telaprevir combination treatment for hepatitis C virus infection.
N Engl J Med. 2011 Sep 15;365(11):1014-24. doi: 10.1056/NEJMoa1014463.
3
The HCV NS5B nucleoside and non-nucleoside inhibitors.
Clin Liver Dis. 2011 Aug;15(3):611-26. doi: 10.1016/j.cld.2011.05.003.
4
Multiple ascending dose study of BMS-790052, a nonstructural protein 5A replication complex inhibitor, in patients infected with hepatitis C virus genotype 1.
Hepatology. 2011 Dec;54(6):1956-65. doi: 10.1002/hep.24609.
5
Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections.
Gastroenterology. 2011 Sep;141(3):881-889.e1. doi: 10.1053/j.gastro.2011.05.046. Epub 2011 May 31.
6
Telaprevir for retreatment of HCV infection.
N Engl J Med. 2011 Jun 23;364(25):2417-28. doi: 10.1056/NEJMoa1013086.
7
Telaprevir for previously untreated chronic hepatitis C virus infection.
N Engl J Med. 2011 Jun 23;364(25):2405-16. doi: 10.1056/NEJMoa1012912.
8
Boceprevir for previously treated chronic HCV genotype 1 infection.
N Engl J Med. 2011 Mar 31;364(13):1207-17. doi: 10.1056/NEJMoa1009482.
9
Boceprevir for untreated chronic HCV genotype 1 infection.
N Engl J Med. 2011 Mar 31;364(13):1195-206. doi: 10.1056/NEJMoa1010494.
10
Cyclophilin inhibitors for the treatment of HCV infection.
Curr Opin Investig Drugs. 2010 Aug;11(8):911-8.
Zotero 插件